<DOC>
	<DOC>NCT00957957</DOC>
	<brief_summary>This study will examine changes in various gut-derived hormones in obese type 2 diabetic patients before and after elective bariatric surgery.</brief_summary>
	<brief_title>Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Obesity, Morbid</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Documented type 2 diabetes with total disease duration â‰¤10 years BMI of at least 35 kg/m^2 Patient is a surgical candidate for either RYGBP, GBS or vertical sleeve gastrectomy (VSG) Any illness that might confound the results of the study or pose additional risk to the patient by participation History of stroke, seizures, or other major neurological disorder History of cancer Patient uses or has used any medication that can alter body weight Patient is unwilling or unable to follow study procedures</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>